Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-073769
Filing Date
2025-05-16
Accepted
2025-05-16 18:05:53
Documents
1
Period of Report
2025-05-14

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6196
  Complete submission text file 0000950170-25-073769.txt   7572
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Issuer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address
Kay Sabrina (Reporting) CIK: 0001835895 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50865 | Film No.: 25960948